Francesco Marchesi

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications

Real-Life Study on Gilteritinib-Related Infections (GilteRInf): An Italian SEIFEM Study.

Real-Life Study on Gilteritinib-Related Infections (GilteRInf): An Italian SEIFEM Study.

Journal: American journal of hematology
Published: May 07, 2026

Editorial: Multidrug-resistant Gram-negative bacteria in fragile hosts.

Editorial: Multidrug-resistant Gram-negative bacteria in fragile hosts.

Journal: Frontiers in microbiology
Published: April 25, 2026

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Journal: Blood reviews
Published: March 18, 2026

Characteristics and Outcomes of Progressive Multifocal Leukoencephalopathy in Hematologic Malignancies: A SEIFEM Retrospective Review.

Characteristics and Outcomes of Progressive Multifocal Leukoencephalopathy in Hematologic Malignancies: A SEIFEM Retrospective Review.

Journal: American journal of hematology
Published: February 09, 2026

Optimizing Treatment, Minimizing Risk: Therapeutic Drug Monitoring in Hematological Malignancies.

Optimizing Treatment, Minimizing Risk: Therapeutic Drug Monitoring in Hematological Malignancies.

Journal: Mediterranean journal of hematology and infectious diseases
Published: December 15, 2025

Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry.

Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry.

Journal: Open forum infectious diseases
Published: September 24, 2025

Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry.

Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry.

Journal: American journal of hematology
Published: July 22, 2025

Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.

Author's Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al.

Journal: Leukemia
Published: June 18, 2025

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Journal: Blood advances
Published: May 19, 2025

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Journal: Blood advances
Published: May 19, 2025

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Journal: Blood advances
Published: May 19, 2025

Gilteritinib in FLT3-mutated acute myeloid leukemia: A real-world Italian experience.

Gilteritinib in FLT3-mutated acute myeloid leukemia: A real-world Italian experience.

Journal: Cancer
Published: May 06, 2025
Showing 1-12 of 175

Last Updated: 09/26/2026